Clinical Implications of Leaflet Thrombosis After Percutaneous Pulmonary Valve Implantation With the Pulsta Valve: Life‐Long Aspirin Is Necessary?
HALT is a relatively common finding following PPVI, particularly in patients receiving short-term antiplatelet therapy and larger valve sizes. These findings support routine imaging surveillance and consideration of individualized antithrombotic strategies in post-PPVI management.
Authors
- Seung-Min Baek
- Woo Young Park (ORCID: https://orcid.org/0000-0002-5933-1010)
- Eun Jung Bae (ORCID: https://orcid.org/0000-0002-1334-1520)
- Susan Taejung Kim (ORCID: https://orcid.org/0000-0002-0096-7364)
- Gi Beom Kim (ORCID: https://orcid.org/0000-0002-7880-280X)
- Sang Yun Lee (ORCID: https://orcid.org/0000-0002-3071-2661)
- Mi Kyoung Song (ORCID: https://orcid.org/0000-0003-1998-7872)
- Yoon Seong Lee (ORCID: https://orcid.org/0000-0001-6833-6596)
Institutions
- Seoul National University Hospital (KR)
- Seoul National University Children's Hospital (KR)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-08-17
- DOI
- https://doi.org/10.1002/ccd.70095
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00